Article
Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA.
Molecular oncology - 1 Sept 2021
Pasini Luigi, Notarangelo Michela, Vagheggini Alessandro, Burgio Marco Angelo, Crinò Lucio, Chiadini Elisa, Prochowski Andrea Iamurri, Delmonte Angelo, Ulivi Paola, D'Agostino Vito Giuseppe
Abstract excerpt
The mutational status of the epidermal growth factor receptor (EGFR) guides the stratification of non-small cell lung cancer (NSCLC) patients for treatment with tyrosine kinase inhibitors (TKIs). A liquid biopsy test on cell-free DNA is recommended as a clinical decision-supporting tool, although it has limited sensitivity. Here, we comparatively investigated the extracellular vesicle (EV)-RNA as an independent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
